semaj83/ctmatch_classification huggingface dataset:
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-35.0,  Temporomandibular Disorder Neck Pain be Adnan Menderes University student female gender express consent to participate voluntarily in the study  with recent trauma to head and face history of systematic diseases and neurological disorders currently an ongoing orthodontic treatment
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Depressive Symptoms Must live in Hillsdale County, Michigan for at least one year Positive screen for at least mild depressive symptoms based on the the Patient Health Questionnaire-9 (PHQ-9>=5)  Non-English speaking Currently receiving cognitive behavioral therapy (CBT) for depression Ever completed a course of cognitive behavioral therapy (CBT; >=8 sessions) Diagnosis of a psychotic disorder Current use of opiates or freebase cocaine Prominent suicidal/homicidal ideation with imminent risk
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-89.0,  Gynecologic Cancer Diagnosis of gynecologic malignancy No chemotherapy in the last 12 months Scheduled to receive Carboplatin (AUC>=4) and Paclitaxel every three weeks ECOG performance status 0 or 1 English speaking Willing and able to provide informed consent Laboratory values within protocol-defined parameters No vomiting in the 24 hours prior to initiating chemotherapy If childbearing potential exists, negative pregnancy test within 7 days prior to registration  Significant cognitive compromise History of CNS disease (e.g. brain metastases, seizure disorder, dementia) Current or recent (within 30 days) treatment with another antipsychotic agent (antidepressant medications are OK) Concurrent radiotherapy treatment Known hypersensitivity to olanzapine Known cardiac arrhythmia, uncontrolled congestive heart failure or acute myocardial infarction within the last six months History of diabetes mellitus on medication (insulin or oral glycemic agent) Alcohol abuse / chronic alcoholism History of closed angle glaucoma Current enrollment in other clinical trials
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Complicated Urinary Tract Infection Including Acute Pyelonephritis Male and female subjects aged 18-75 years 2. Have a diagnosis of cUTI or AP as defined below: 1. cUTI definition At least Two of the following signs and symptoms Chills, rigors, or fever; fever must be observed and documented by a health care provider (tympanic temperature ≥37.3°C) Flank pain or Lower abdominal pain Dysuria, urgency to void, or increased urinary frequency Nausea or vomiting Costovertebral angle tenderness or renal percussive pain on physical examination Blood leukocytes above upper limit of normal value And at least One of the following risk factors for cUTI Implanted urinary tract instrumentation (e.g., nephrostomy tube, ureteric stents), ongoing intermittent bladder catheterization, or presence of an indwelling bladder catheter (Note: bladder catheters prior to Screening should be expected to remove during study period post-void residual urine volume of ≥ 100 mL  Receipt of potentially effective antibiotic therapy more than 24h within 72 h prior to randomization 2. Anticipated concomitant use of other systemic antibiotic drugs during the study period 3. Anticipated continnue to preventive anti-infectious therapy after cUTI patients completed investigational drug treatment 4. Presence of any known or suspected disease or condition as following Uncomplicated urinary tract infection (uUTI) Fungal Urinary tract infection Perinephric or renal corticomedullary abscess Polycystic kidney disease Urinary tuberculosis Obstructive uropathy(e.g.congenital malformation) unable to remove during treatment Ideal loop surgery or vesicoureteral reflux Permannent bladder catheterization or long term indwelling nephrostomy tube Previous or planned renal transplantation
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  COVID-19 Pregnancy Complications Women who deliver at a selected hospital participating in the MFMU Network on selected dates sent by the Data Coordinating Center from March 1, 2019, through Dec, 31, 2019. Women delivered in the calendar year 2019 will serve as the controls (before pandemic) Women who deliver at a selected hospital participating in the MFMU Network on selected dates sent by the Data Coordinating Center from March 1, 2020, through Dec, 31, 2020. Women delivered in the calendar year 2020 will be considered as deliveries during the pandemic (research question 1) and non-confirmed positives as controls (research question 2) Pregnant and postpartum (within 6 weeks of delivery) women with confirmed COVID-19 infection from March 1, 2020, through Dec, 31, 2020 and who deliver on or before December 31, 2020. Both those with COVID-19 infection requiring in-patient management and those managed as out-patients will be included. Confirmed COVID-19 infection is defined as a positive COVID-19 viral (i.e., nucleic acid or antigen tests) test during pregnancy through 42 days postpartum  Multifetal gestation higher than twins
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Thrombotic Patients Diagnosis of Myeloproliferative Neoplasia Impact of Treatment With Cytoreducing Agent Adult ≥18 years old Diagnosis of a deep arterial or venous thrombotic event verified by imaging (Doppler or CT scan) Diagnosis of MPN with normal CBC according to WHO 2017 characterized by the detection of a molecular abnormality JAK2V617F mutation (regardless of allelic load), CALR or MPL and/or a bone marrow biopsy with abnormalities in favor of MPN Normal blood cell count not suggestive of polycythemia vera (hematocrit<48% and hemoglobin<16g/dL for women; hematocrit<49% and hemoglobin<16.5g/dL for men), essential thrombocythemia (platelets<450 G/L) nor myelofibrosis (white blood cell count<11 G/L, no anemia or erythromyelemia associated with splenomegaly) at the time of the thrombotic event  Minors (<18 years of age) Microcirculation disorders (erythromelalgia, headaches, paresthesia, ischemia of the extremities) Superficial or deep arterial or venous thrombosis NOT verified by imaging Diagnosis or history of TE, PV or myelofibrosis at time of first thrombotic event Diagnosis of mixed myelodysplastic/myeloproliferative syndrome Diagnosis of unclassifiable MPN with excess blasts at the onset or signs of myelodysplasia as defined by the WHO 2017 classification
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Covid19 Pregnancy Complications Premature Rupture of Membrane Abruptio Placentae Prelabor Rupture of Membranes Stillbirth - Patients eligible for follow-up o target population will be any pregnant woman who is suspected or needs to be ruled out as having a SARS-CoV-2 infection at any time during pregnancy with positive test results for SARS-CoV-2 by PCR. Information regarding each pregnant woman's demographic characteristics, comorbidities and current obstetric history was extracted from the medical history and the patient interview; subsequently, age and race were categorized according to the classification used by the Center for Disease Control and Prevention (CDC) (17). For the selection of the control group to be collected in the same database, patients with a negative COVID-19 delivery diagnosed by PCR screening at delivery, or less than 3 days before, were considered  Pregnant women under the following conditions will be excluded from the registry Inability to give informed consent in the absence of a legal representative If, in the opinion of the researcher, findings in the physical examination, anomalies in the results of the laboratory tests or other medical, social or psychosocial factors could have a negative influence Loss of follow-up data prior to 6 weeks postpartum
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Prostatic Hyperplasia Diagnosis of LUTS secondary to BPH refractory to/contraindicated for medical treatment or not patient preference Moderate to severe urinary symptoms on IPSS (IPSS score 8 or over) Qmax <=15ml/sec, based on flowmetry Unsuitable for TURP or refuses surgery Ability to understand and the willingness to sign an informed consent Prostate volume > 80 milliliters Men with low-risk prostate cancer (T1c, Gleason score <=6 on a maximum of 3 biopsies) who have LUTS due to a large BPH component are eligible Indwelling or intermittent catheter is allowed  History of bladder cancer Previous pelvic radiation for cancer treatment Current bladder stones Significant bladder diverticula Current urethral strictures or bladder neck contracture Neurologic conditions such as multiple sclerosis, Parkinson's disease and other neurological diseases known to affect bladder function Neurogenic bladder without obstruction Active urinary tract infection at the time of intervention unless in case of regular catheter dependence and thought to represent colonization Documented bacterial prostatitis in the last year Severe atheromatous disease or other pathology preventing catheter-based intervention (as rated on CT angiography by an interventional radiologist)
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Urinary Tract Infections Urinary Stone Group 1. Cystitis Symptoms of dysuria, pollakiuria, no fever AND urine-stix positive for leucocytes OR positive culture (>10E5 cfu/ml) Group 2. Pyelonephritis Unilateral flank pain, pollakiuria, dysuria, fever (>38.5°C) AND urine-stix positive for leucocytes OR positive culture (>10E5 cfu/ml)  (both groups) known urinary tract anatomic abnormalities Presence of a urine catheter Sepsis septic shock Patient taking drug interfering with urine pH (diuretics, citrate, acetazolamide, topiramate,...) Patients with UTI diagnosed in the preceding month Patients having received antibiotics during the preceding month Male patient with a diagnosis of prostatitis Presence of infected kidney cyst
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Upper Gastrointestinal Symptoms Patient is able to provide informed consent 2. Patient has appropriate indications for EGD including symptoms of, but not limited to upper abdominal pain, acid reflux, heartburn, iron deficiency anemia, weight loss, bloating, belching, nausea, vomiting and atypical chest pain  Patient with dysphagia. 2. Patient with previous intestinal surgery. 3. Patient with Crohn's disease or other potential obstructive conditions, unless there is a recent CTE, MRE or patency capsule performed to an obstructive lesion that may retain the capsule. 4. Female patient who is pregnant. 5. Patient with implanted medical device that would be potentially affected by magnets or radiofrequency emissions (e.g., pacemakers, implanted cardiac defibrillators)
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Urinary Tract Infections Age ≥ 18 years Clinical diagnosis of pyelonephritis Antibiotic treatment with cefuroxime Urine culture positive for Escherichia coli  Use of antibiotic for less than 24 hours Not availability of antimicrobial susceptibility testing Use of urinary catheter for more than 30 days
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Community Mental Health Adults aged 18 years and above who live in the community where data will be collected  Individuals with acute illnesses that will prevent them from providing information during data collection
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 14.0-49.0,  Severe Infection Patients in a state of pregnancy with a single fetus between 14 and 49 years old Pregnant women (any gestational age) defined as a positive gravindex test and an obstetric ultrasound to prove it Any suspected or confirmed infection during current hospital stay (primary admission or readmission) with or without organ dysfunction Any clinical signs suggestive of infection (eg, fever) Request for culture of body fluids (blood, urine, cerebrospinal fluid, etc.) or swab specimen (nasopharyngeal, oropharyngeal) Non-prophylactic use of antibiotics or other antimicrobials during admission or during hospital stay Any health care related infection (eg, surgical site, episiotomy, IV, venipuncture, urinary catheterization, central line, etc.) Urinary tract infection of the lower urinary tract that requires hospitalization and in-hospital management for more than 48 hours Herpes simplex, herpes zoster (shingles) with associated liver failure. Note: observations on the Eligible women who remain in the health center for 12 hours or more, regardless of formal administrative admission, will be included in the study  Pregnant women of any age who do not sign the informed consent Pregnant minors who do not sign the consent Any non-serious or localized infection Vaginosis, candidiasis Fungal skin infections (athlete's foot, ringworm) Otitis o Pharyngitis Any chronic uncomplicated infection Sexually transmitted infections (gonorrhea, syphilis, Trichomonas, chlamydia, hepatitis, HIV) Tuberculosis Any colonization Microorganisms without clinical signs / symptoms)